Holen Sie sich die Stockscreener-App
1.03
0.96%
-0.01
Handel nachbörslich:
1.03
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CTSO?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$1.04
Offen:
$1.01
24-Stunden-Volumen:
56,878
Relative Volume:
0.22
Marktkapitalisierung:
$56.60M
Einnahmen:
$33.79M
Nettoeinkommen (Verlust:
$-18.67M
KGV:
-2.8755
EPS:
-0.3582
Netto-Cashflow:
$-19.17M
1W Leistung:
+9.84%
1M Leistung:
+27.14%
6M Leistung:
-6.36%
1J Leistung:
+1.98%
1-Tages-Spanne:
$1.01
$1.0396
1-Wochen-Bereich:
$0.92
$1.1418
52-Wochen-Spanne:
$0.70
$1.59
Cytosorbents Corp Stock (CTSO) Company Profile
Firmenname
Cytosorbents Corp
Sektor
Branche
Telefon
973-329-8885
Adresse
305 COLLEGE ROAD EAST, PRINCETON, NJ
Vergleichen Sie CTSO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CTSO
Cytosorbents Corp
|
1.03 | 56.60M | 33.79M | -18.67M | -19.17M | -0.3582 |
|
ABT
Abbott Laboratories
|
113.48 | 196.83B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
383.42 | 146.17B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
98.66 | 145.41B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
88.08 | 112.94B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
69.78 | 41.16B | 6.60B | 4.16B | 490.10M | 6.93 |
Cytosorbents Corp Stock (CTSO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-09-07 | Eingeleitet | B. Riley Securities | Buy |
| 2021-10-14 | Fortgesetzt | B. Riley Securities | Buy |
| 2020-09-17 | Eingeleitet | Jefferies | Buy |
| 2020-09-01 | Eingeleitet | SVB Leerink | Outperform |
| 2017-08-08 | Bestätigt | Maxim Group | Buy |
| 2016-10-26 | Eingeleitet | Aegis Capital | Buy |
| 2016-05-24 | Eingeleitet | Maxim Group | Buy |
| 2015-10-29 | Hochstufung | WBB Securities | Speculative Buy → Buy |
| 2015-05-12 | Bestätigt | MLV & Co | Buy |
| 2015-04-01 | Bestätigt | MLV & Co | Buy |
| 2015-03-05 | Eingeleitet | MLV & Co | Buy |
| 2015-02-25 | Eingeleitet | WBB Securities | Speculative Buy |
| 2015-01-27 | Bestätigt | H.C. Wainwright | Buy |
Alle ansehen
Cytosorbents Corp Aktie (CTSO) Neueste Nachrichten
CytoSorbents Strengthens Balance Sheet with Successful Conclusion of Rights Offering - Defense World
Cytosorbents Boosts Liquidity with Successful Rights Offering - Yahoo Finance
Cytosorbents (NASDAQ:CTSO) Given Buy Rating at D. Boral Capital - Defense World
D. Boral Capital Reiterates Buy Rating for Cytosorbents (NASDAQ:CTSO) - MarketBeat
Expert Outlook: CytoSorbents Through The Eyes Of 7 Analysts - Benzinga
CytoSorbents closes oversubscribed rights offering - TipRanks
CytoSorbents Raises $6.25M in Oversubscribed Rights Offering, Unlocks $5M Restricted Cash - StockTitan
Cytosorbents (NASDAQ:CTSO) Now Covered by StockNews.com - Defense World
Cytosorbents (NASDAQ:CTSO) Coverage Initiated by Analysts at StockNews.com - MarketBeat
Cytosorbents Co. (NASDAQ:CTSO) Stake Boosted by Geode Capital Management LLC - Defense World
Skylands Capital, LLC Increases Stake in CytoSorbents Corp - GuruFocus.com
Revenue Surge & Breakthrough Margins Fuel Growth in Critical Care Tech - Streetwise Reports
CytoSorbents opens new sales subsidiary in Dubai - Investing.com
CytoSorbents Expands Global Reach with Strategic Dubai Hub for Middle East & Africa Growth - StockTitan
Cytosorbents (NASDAQ:CTSO) Earns Hold Rating from Analysts at StockNews.com - Defense World
CytoSorbents reported strong Q4 results, says D. Boral Capital - Yahoo Finance
Health Care Equipment Supplier CytoSorbents Shares Dip Despite Projected Revenue Growth - Benzinga
Cytosorbents' (CTSO) Buy Rating Reiterated at D. Boral Capital - MarketBeat
CytoSorbents reports revenue growth in Q4 - Investing.com
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product Revenue - Quantisnow
StockNews.com Initiates Coverage on Cytosorbents (NASDAQ:CTSO) - MarketBeat
Cytosorbents (NASDAQ:CTSO) Now Covered by Analysts at StockNews.com - Defense World
Comparing Cytosorbents (NASDAQ:CTSO) & Presbia (OTCMKTS:LENSF) - Defense World
CytoSorbents begins rights offering for stockholders - Investing.com
CytoSorbents Launches $1.00 Rights Offering with Discounted Warrant Package for Shareholders - StockTitan
CytoSorbents Rights Offering Begins - GlobeNewswire
StockNews.com Begins Coverage on Cytosorbents (NASDAQ:CTSO) - Defense World
Peter J. Mariani Purchases 20,000 Shares of Cytosorbents Co. (NASDAQ:CTSO) Stock - MarketBeat
Cytosorbents CFO Peter J. Mariani buys $19,294 in common stock - Investing.com India
Cytosorbents CFO Peter J. Mariani buys $19,294 in common stock By Investing.com - Investing.com Nigeria
Cytosorbents Co. (NASDAQ:CTSO) Short Interest Update - MarketBeat
Cytosorbents CFO Peter Mariani buys $27,974 in stock - Investing.com
KORU Medical Systems (NASDAQ:KRMD) and Cytosorbents (NASDAQ:CTSO) Head-To-Head Comparison - Defense World
CytoSorbents to Host Investor Meetings in San Francisco During J.P. Morgan Healthcare Conference Week - Yahoo Finance
CytoSorbents Announces Commencement of Shareholder Rights Warrant Offering - Defense World
CTSOCytosorbents Corp. Latest Stock News & Market Updates - StockTitan
CytoSorbents sets terms for anticipated Rights Offering - Investing.com
SEC Form FWP filed by Cytosorbents Corporation - Quantisnow
CytoSorbents Announces Rights Offering - Quantisnow
CTSO (CytoSorbents) 3-Year Revenue Growth Rate : -11.80% (As of Sep. 2024) - GuruFocus.com
CytoSorbents to Participate at the Piper Sandler 36th Annual Healthcare Conference - StockTitan
Cytosorbents (NASDAQ:CTSO) Coverage Initiated at StockNews.com - Defense World
Granahan Investment Management Reduces Stake in CytoSorbents Cor - GuruFocus.com
FY2024 EPS Estimates for Cytosorbents Decreased by Analyst - Defense World
FY2024 EPS Estimate for Cytosorbents Decreased by Analyst - MarketBeat
Several Insiders Invested In Cytosorbents Flagging Positive News - Yahoo Finance
Cytosorbents Corporation (NASDAQ:CTSO) Q3 2024 Earnings Call Transcript - Insider Monkey
CytoSorbents And Converge Biotech Announce Strategic - GlobeNewswire
CytoSorbents Expands Into India Through Strategic Converge Biotech Partnership | CTSO Stock News - StockTitan
CytoSorbents Corp (CTSO) Q3 2024 Earnings Call Highlights: Stron - GuruFocus.com
Finanzdaten der Cytosorbents Corp-Aktie (CTSO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.25%
0.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):